STOCK OPTIONS AND WARRANTS | NOTE 12 – STOCK OPTIONS AND WARRANTS During 2008, the Board of Directors (“Board”) of the Company adopted the 2008 Equity Incentive Plan (“2008 Plan”) that was approved by the stockholders. Under the 2008 Plan, the Company was authorized to grant options to purchase up to 25,000,000 shares of common stock to any officer, other employee or director of, or any consultant or other independent contractor who provides services to the Company. The 2008 Plan was intended to permit stock options granted to employees under the 2008 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the 2008 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”). As of June 30, 2020, options to purchase 8,400,000 shares of common stock have been issued and are unexercised, and 0 shares are available for grants under the 2008 Plan. The 2008 Plan expired on March 3, 2019. During 2013, the Board adopted the 2013 Equity Incentive Plan (“2013 Plan”), which was approved by stockholders at the 2013 annual meeting of stockholders. Under the 2013 Plan, the Company is authorized to grant awards of stock options, restricted stock, restricted stock units and other stock-based awards of up to an aggregate of 5,000,000 shares of common stock to any officer, employee, director or consultant. The 2013 Plan is intended to permit stock options granted to employees under the 2013 Plan to qualify as Incentive Stock Options. All options granted under the 2013 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be Non-Statutory Stock Options. As of June 30, 2020, under the 2013 Plan grants of restricted stock and options to purchase 4,000,000 shares of common stock have been issued and are unvested and unexercised, and 1,000,000 shares of common stock remain available for grants under the 2013 Plan. The 2013 Plan is administered by the Board or its compensation committee, which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant, including the vesting thereof, subject to the terms of the 2013 Plan. In connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). Prior to January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the volatility of other public companies that are in closely related industries to the Company. Beginning January 1, 2014, volatility in all instances presented is the Company’s estimate of volatility that is based on the historical volatility of the Company’s common stock. The following table presents the weighted-average assumptions used to estimate the fair values of the stock options granted by REGO during the six months ended June 30, 2020: Risk Free Interest Rate 1.0 % Expected Volatility 141.4 % Expected Life (in years) 2.0 Dividend Yield 0 % Weighted average estimated fair value of options during the period $ 0.07 The following table summarizes the activities for REGO’s stock options for the six months ended June 30, 2020: Options Outstanding Weighted - Average Remaining Aggregate Weighted- Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 13,185,000 $ 0.69 2.4 $ - Granted 325,000 0.90 1.8 - Expired (160,000 ) 0.86 - - Balance at June 30, 2020 13,350,000 $ 0.69 1.9 $ 5 Exercisable at June 30, 2020 13,216,667 $ 0.69 1.9 $ 5 Exercisable at June 30, 2020 and expected to vest thereafter 13,350,000 $ 0.69 1.9 $ 5 (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the closing stock price of $0.21 for REGO’s common stock on June 30, 2020. For the three and six months ended June 30, 2020, Rego expensed $25,785 and $51,447 and for the three and six months ended June 30, 2019, Rego expensed $59,636 and $254,351 with respect to options. As of June 30, 2020, there was no unrecognized compensation cost related to outstanding stock options. The difference between the stock options exercisable at June 30, 2020 and the stock options exercisable and expected to vest relates to management’s estimate of options expected to vest in the future. The following table summarizes the activities for REGO’s unvested stock options for the six months ended June 30, 2020: Unvested Options Weighted - Average Grant Number of Date Fair Shares Value Balance at December 31, 2019 233,333 $ 0.20 Granted 325,000 0.05 Expired/cancelled (100,000 ) 0.25 Vested (325,000 ) 0.05 Balance at June 30, 2020 133,333 $ 0.25 During the six months ended June 30, 2020, the Company issued warrants to purchase 1,000,000 shares of common stock commensurate with a consulting agreement. The warrants were valued at $124,485 fair value, using the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 139.0 to 140.4%, risk free interest rate of 0.19% to 0.36% and expected life of 2 years. The fair value of the warrants was $124,485 and was expensed immediately. During the three and six months ended June 30, 2020, the Company expensed $49,599 and $124,485 and during the three and six months ended June 30, 2019, the Company expensed $0, relative to warrants. The following table summarizes the activities for REGO’s warrants for the six months ended June 30, 2020: Remaining Aggregate Weighted- Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 4,427,020 $ 0.90 1.0 $ - Granted 1,000,000 0.90 1.8 - Expired (1,852,020 ) 0.90 - Balance at June 30, 2020 3,575,000 $ 0.90 1.3 $ - Exercisable at June 30, 2020 3,575,000 $ 0.90 1.3 $ - Exercisable at June 30, 2020 and expected to vest thereafter 3,575,000 $ 0.90 1.3 $ - (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.21 for Rego’s common stock on June 30, 2020. All warrants were vested on the date of grant. The following table summarizes the activities for ZS’s stock options for the six months ended June 30, 2020: Options Outstanding Weighted - Average Remaining Aggregate Weighted- Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 2,400,000 $ 5.00 3.6 $ - Balance at June 30, 2020 2,400,000 $ 5.00 3.1 $ - Exercisable at June 30, 2020 2,400,000 $ 5.00 3.1 $ - Exercisable at June 30, 2020 and expected to vest thereafter 2,400,000 $ 5.00 3.1 $ - (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the value of $4.00 for ZS’s common stock on June 30, 2020. For the three and six months ended June 30, 2020, ZS expensed $0 with respect to options and for the three and six months ended June 30, 2019, ZS expensed $0 and $28,051 with respect to options. The following table summarizes the activities for ZS’s warrants for the six months ended June 30, 2020: Warrants Outstanding Weighted - Average Remaining Aggregate Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 83,334 $ 3.00 1.8 $ 83 Balance at June 30, 2020 83,334 $ 3.00 1.3 $ 83 Exercisable at June 30, 2020 83,334 $ 3.00 1.3 $ 83 Exercisable at June 30, 2020 and expected to vest thereafter 83,334 $ 3.00 1.3 $ 83 (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the value of $4.00 for ZS’s common stock on June 30, 2020. For the three and six months ended June 30, 2020 and 2019, ZS expensed $0 with respect to warrants. The following table summarizes the activities for ZBS’s stock options for the six months ended June 30, 2020: Options Outstanding Weighted - Average Remaining Aggregate Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 100,000 $ 5.00 0.7 $ - Balance at June 30, 2020 100,000 $ 5.00 0.2 $ - Exercisable at June 30, 2020 100,000 $ 5.00 0.2 $ - Exercisable at June 30, 2020 and expected to vest thereafter 100,000 $ 5.00 0.2 $ - (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the value of $0.01 for ZBS’s common stock on June 30, 2020. For the three and six months ended June 30, 2020 and 2019, ZBS expensed $0 with respect to options. The following table summarizes the activities for ZCS’s stock options for the six months ended June 30, 2020: Options Outstanding Remaining Aggregate Weighted- Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 2,200,000 $ 5.00 3.8 $ - Balance at June 30, 2020 2,200,000 $ 5.00 3.3 $ - Exercisable at June 30, 2020 2,200,000 $ 5.00 3.3 $ - Exercisable at June 30, 2020 and expected to vest thereafter 2,200,000 $ 5.00 3.3 $ - (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the value of $0.01 for ZCS’s common stock on June 30, 2020. For the three and six months ended June 30, 2020 and 2019, ZCS expensed $0 with respect to options. The following table summarizes the activities for ZPS’s stock options for the six months ended June 30, 2020: Options Outstanding Weighted - Average Remaining Aggregate Contractual Intrinsic Number of Average Term Value Shares Exercise Price (in years) (in 000's) (1) Balance at December 31, 2019 100,000 $ 5.00 0.7 $ - Balance at June 30, 2020 100,000 $ 5.00 0.2 $ - Exercisable at June 30, 2020 100,000 $ 5.00 0.2 $ - Exercisable at June 30, 2020 and expected to vest thereafter 100,000 $ 5.00 0.2 $ - (1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the value of $0.01 for ZPS’s common stock on June 30, 2020. For the three and six months ended June 30, 2020 and 2019, ZPS expensed $0 with respect to options. |